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OBJECTIVE
To evaluate whether the diagnosis of pediatric type 1 diabetes or its acute com-
plications changed during the early phase of the coronavirus disease 2019
(COVID-19) pandemic in Italy.
RESEARCH DESIGN AND METHODS
Thiswas a cross-sectional,Web-based surveyof all Italianpediatric diabetes centers
to collect diabetes, diabetic ketoacidosis (DKA), and COVID-19 data in patients
presentingwith new-onset or established type 1 diabetes between20 February and
14 April in 2019 and 2020.
RESULTS
Fifty-three of 68 centers (77.9%) responded. There was a 23% reduction in new
diabetes cases in 2020 comparedwith 2019. Among those newly diagnosed patient
who presented in a state of DKA, the proportion with severe DKA was 44.3% in
2020 vs. 36.1% in 2019 (P5 0.03). Therewere nodifferences in acute complications.
Eight patients with asymptomatic or mild COVID-19 had laboratory-confirmed
severe acute respiratory syndrome coronavirus 2.
CONCLUSIONS
The COVID-19 pandemicmight have altered diabetes presentation and DKA severity.
Preparing for any “secondwave” requires strategies to educate and reassure parents
about timely emergency department attendance for non–COVID-19 symptoms.
At its peak, coronavirus disease 2019 (COVID-19) significantly reduced pediatric
emergency department (ED) access,most likely due to the fear of infection (1). During
the pandemic, the International Society for Pediatric and Adolescent Diabetes
received information from its members about several new type 1 diabetes cases or
diabetic ketoacidosis (DKA) episodes where hospitalization was delayed due to the
closure of non–COVID-19 services (2). There were also concerns that parents had
delayed seeking timelymedical advice for childrenwith symptomsof diabetes or DKA,
resulting in increased numbers of presentations of severe DKA. Based on these
anecdotal cases in Italy and other countries (2), we hypothesized that the COVID-19
pandemicmighthave affected thenumberofnewdiabetes diagnoses and the severity
of DKA. We therefore conducted a survey to evaluate whether the diagnosis of
pediatric type 1 diabetes or its acute complications changed during the early phase of
the COVID-19 pandemic in Italy compared with the same period in 2019.
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RESEARCH DESIGN AND METHODS
This was a cross-sectional electronic sur-
vey of all 68 Italian pediatric diabetes
centers (3), including all tertiary referral
centers in Italy. Each center was asked to
review all records of patients ,15 years
of age with recorded onset of diabetes
between 20 February 2020 and 14 April
2020 and during the same period in 2019.
The survey was Web based with data
collection centralized at the Department
of Health Sciences, University of Piemonte
Orientale.
Each center provided the number of
patients diagnosed with type 1 diabetes,
howmany had DKA and its severity, how
many were diagnosed with COVID-19,
and how many patients with established
diabetes had DKA or severe hypoglycemia.
Type 1 diabeteswas defined according
to autoantibody positivity. DKA was de-
fined according to International Society
for Pediatric and Adolescent Diabetes
criteria (blood glucose .11 mmol/L
[;200 mg/dL], venous pH ,7.3 or bi-
carbonate ,15 mmol/L, ketonemia and
ketonuria), with DKA severity categorized
as follows: mild, venous pH ,7.3 or
bicarbonate ,15 mmol/L; moderate, pH
,7.2, bicarbonate ,10 mmol/L; and se-
vere, pH ,7.1, bicarbonate ,5 mmol/L
(4). Severe hypoglycemia was defined as
an episode with loss of consciousness or
requiring hospitalization.
The x2 test was used to evaluate
differencesbetween2020and2019data.
P , 0.05 was deemed statistically sig-
nificant. Statistical analyses were per-
formed using SPSS Statistics, version
23 (IBM Statistics, Chicago, IL).
RESULTS
Of the 68 centers belonging to the Italian
Society for Pediatric Endocrinology and
Diabetes, 53 (77.9%) completed the
Web-based survey and returned com-
plete data, which included all diabetes
tertiary referral centers (n5 39) in Italy.
The results of the survey are shown in
Table 1. Between 20 February 2020 and
14 April 2020, 160 children aged 0–
14 years were diagnosed with type 1
diabetesd23% lower than in 2019. DKA
of any severity was observed in 61 of 160
patients (38.1%) in 2020 and in 86 of
208 patients in 2019 (41.3% [not signif-
icantly different]). Whereas the overall
proportion of patients with newly diag-
nosed diabetes with severe DKA was
similar in 2020 and 2019 (16.9% vs.
14.9%, respectively), among all patients
who presented in a state of DKA, the
proportionwith severeDKAwas 44.3% in
2020 vs. 36.1% in 2019 (P5 0.03) (Table 1).
DKA episodes and severe hypoglyce-
mia requiring hospitalization in patients
with established diabetes were similar
between the twoperiods, although there
were slightly fewer cases in 2020 (13DKA
episodes in 2020 vs. 22 in 2019 and 10
severe hypoglycemia cases in 2020 vs.
13 in 2019).
During the observation period, only
eight patients were diagnosed with
COVID-19 (range 6–16 years of age): one
atdiabetesonset and sevenpatientswith
established diabetes (diabetes for 1–11
years), all of whom were asymptomatic
(n5 4) or had only mild symptoms (n5
4).All hadnasopharyngeal swabspositive
for severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) by RT-PCR;
one also had confirmatory serological
detectionofSARS-CoV-2–specificantibodies.
CONCLUSIONS
In this study, theDiabetes StudyGroupof
the Italian Society for Pediatric Endocri-
nology andDiabetes investigatedwhether
COVID-19 affected children with new-onset
and existing type 1 diabetes in the first
2 months of the pandemic in Italy. During
the observation period, there were 23%
fewer new diabetes cases compared with
the same period in 2019, and children
presenting with DKA had more severe DKA
(pH,7.1) in 2020 than in 2019 (44.3% vs.
36%, respectively; P 5 0.03). The lower
number of new-onset diabetes cases dur-
ing theobservationperiodmightbedue to
notonlya fearofSARS-CoV-2exposurebut
also lower exposure to seasonal viruses.
Children stopped going to school on 20
February 2020, thus reducing interper-
sonal interactions and the chance of
acquiring seasonal viruses, which are a
known precipitating factor for type 1
diabetes. The impact of school closures,
quarantine, and lack of exposure to
seasonal viruses on future rates of di-
abetes will be important to quantify.
We did not observe a higher incidence
of acute complications of diabetes during
the first 40 days of the pandemic, with
fewer DKA and severe hypoglycemia
cases than during the same period the
previous year. Perhaps contributing to
this, Tornese et al. (5) reported that
glycemic control of type 1 diabetes in
adolescents usinghybrid closed-loop sys-
tems did not worsen during the COVID-
19 restrictions and actually improved in
those who continued physical activity
during the quarantine. It is also possible
that being quarantined, the fear of be-
coming ill, and the presence of parents/
guardians at home improved self-care
and increased thesupervisionofdiabetes
control.
Although children are generally less
prone to COVID-19 and have a milder
disease course, children with existing
comorbidities could remain at higher risk
of complications (6).Adultswithdiabetes
are at high risk of complications and
death from COVID-19 (7,8), but to our
knowledge there are no equivalent data
for children with diabetes. Furthermore,
it is possible that SARS-CoV-2might itself
be diabetogenic, similar to what was
observed in patients with severe acute
Table 1—Diabetes onset, DKA at onset, and acute complications in the pediatric
population (0–15 years) observed during COVID-19 pandemic (20 February–14
April 2020) compared with the same period in 2019
2020 2019
D Pn % n %
Patients with diabetes onset 160 d 208 d 248 –
Patients with DKA (pH ,7.3) 61 38.1 86 41.3 23.2 0.08
Patients with severe DKA (pH ,7.1) 27 16.9 31 14.9 2.0% 0.09
Proportion of DKA patients with severe DKA 27 44.3 31 36.0 8.3% 0.03
DKA episodes in patients with established diabetes 13 d 22 d 29 d
Severe hypoglycemia episodes in patients with
established diabetes 10 d 13 d 23 d
Severe hypoglycemia was defined as an episode with loss of consciousness or requiring
hospitalization. The value in boldface type represents significant difference between groups.
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respiratory syndromecoronavirus1pneu-
monia (9)dan association that requires
further study in both adults and children.
Only eight of our patients had labo-
ratory confirmation of SARS-CoV-2 in-
fection. These patients were tested due
to having mild COVID-19 symptoms or
because they lived close to a known
positive patient. These low numbers
seem to support the evidence that chil-
dren are generally less prone to COVID-
19 and have a milder disease course
(6,10–12).
As the pandemic continues, further
work is necessary to explore how this
disease affects children to develop best-
evidence guidelines and optimal care for
our vulnerable patients (11). In the ab-
sence of guidelines, themain strategy for
reducing the risk and severity of SARS-
CoV-2 infection in children with diabetes
seems to be optimizing glycemic control
(5,6).
Judicious access to pediatric EDs at any
time is needed to avoid severe con-
sequences. A recently published survey
of pediatric EDs in several European
countries found variability and gaps in pre-
paredness and responses to the COVID-19
pandemic (13). A secure non–COVID-19
path through pediatric EDs is essential to
help and reassure parents bringing their
children to the ED with other conditions
such as diabetes. Specific awareness cam-
paigns could be of help in these difficult
times.
Our study is limited by only comparing
data across two consecutive years, so we
cannot rule out that the 2020 decrease
might reflect random variation. Never-
theless, taken togetherwithoverall changes
in pediatric ED attendance figures during
the pandemic (1), these results should
regardless prompt forward planning to
mitigate the effect any “second wave”
might have on non-COVID-related disease.
Conclusion
These data suggest that during the COVID-
19 pandemic a good number of children
received a delayed diagnosis, altering
the presentation of type 1 diabetes and
severity of DKA. In preparation for any
potential “second wave,” specific strat-
egies are essential to educate and re-
assure parents about timely attendance
at the ED for children with symptoms
that are not related to COVID-19.
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